Beckman Coulter Inc. (NYSE:BEC) reduced its full-year guidance, again.
The Orange County, Calif.-based biomedical testing systems maker reported net earnings of $60 million, or 84 cents per diluted share, on revenue of $902 million during the three months ended June 30. That compares with net earnings of $61 million, or 94 cents per diluted share, on sales of $757 million during the same period last year.
Without $117 million in revenue from a recent Olympus Diagnostics acquisition, net earnings were $45 million or 63 cents per diluted share, off 27 percent and 33 percent, respectively.